Wild Upswing: Genmab Shares Rise Eight Percent After New Cancer Data

Ekstra Bladet

Center

Factuality

Ownership

News about trials with a drug against lymphoma sends Genmab's share price up Tuesday morning

BT

berlingske.dk

Lean Right

View article

Reposted by

berlingske.dk

Lean Right

Factuality

Ownership

News about trials of a drug against lymphoma sends the price of Genmab's shares up on Tuesday morning.

Dagens industri

Factuality

Ownership

Danish pharmaceutical company Genmab rises 8 percent on the Copenhagen Stock Exchange after successful phase 3 results for a treatment for blood cancer.

borsen.dk

Factuality

Ownership

Study data and new price targets send Danish stocks soaring Tuesday morning. And on a day when political uncertainty, high interest rates and AI optimism set the tone on global trading floors, the C25 starts off up 1.38%.